Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 18, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results...

Related Keywords

San Diego ,California ,United States ,Netherlands ,David Schull ,Roberte Hoffman ,Ignacio Guerrero Ros ,Mike Moyer ,Patricky Wen ,Company Quarterly Reports On Form ,Linkedin ,Facebook ,National Cancer Institute ,Prnewswire Kintara Therapeutics Inc ,National Institutes Of Health ,Md Harvard Medical School ,European Association Of Neuro ,Small Business Innovation Research ,Nasdaq ,Company Annual Report On Form ,Company Current Reports On Form ,Us Securities Exchange Commission ,Global Coalition For Adaptive Research ,National Institutes ,Key Opinion Leader ,Harvard Medical School ,John De Groot ,Annual Meeting ,Chief Executive ,Balance Sheet Data ,Operations Data ,Exchange Commission ,Global Coalition ,Adaptive Research ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Sci Advisors ,Managing Director ,Markets ,